Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income (loss)	$ (4,500,294)	$ (329,260)
Bad debt writeoff	(310,272)	(390,000)
Depreciation	90,097	0
Compensation expense - common stock issuance	3,144,536
Changes in operating assets and liabilities:
Accounts receivable	118,711	(354,904)
Other receivable- related party	0	(390,000)
Prepayments and advances	27,455	82,618
Intangibles and Other Assets	(10,858)	0
Accounts payable and accrued expenses	950,873	274,087
Other payable to related party	(69,210)	0
Taxes payables	(6,367)	133,331
Net cash provided by (used in) operating activities	55,217	(194,127)
Cash flows from investing activities:
Purchase of equipment	(47,806)	(8,450)
Net cash (used in) investing activities	(47,806)	(8,450)
Cash flows from financing activities:
Issuance of Preferred stock for cash	171,000
Proceeds from bank loan payable		67,478
Proceeds from note payable		170,000
Proceeds from Director and Officer loans	100,000
Repayment of loans from Directors and Officers	(30,000)
Proceedes from bank loan payable	38,324
Principal repayments of bank loan payable	(37,332)	(64,244)
Principal repayment of Cellcast loan payable	(138,353)
Proceeds from issuing common stock		100
Principal repayments of Tax installments	(66,664)
Net cash provided by financing activities	36,975	173,334
Foreign currency translation adjustment	79,732	(17,650)
Increase (decrease) in cash and cash equivalents	124,118	(46,893)
Cash and cash equivalents at beginning of period	146,331	193,225
Cash and cash equivalents at end of period	270,449	146,331
Cash paid for:
Income tax	91,083
Interest	32,866	24,028
NON-CASH INVESTING ACTIVITIES
Shareholder contribution of equipment		219,780
Payment of accounts receivable with fixed assets		$ 219,389